Model-based effectiveness and cost-effectiveness of risk-based selection strategies for adjuvant chemotherapy in Dutch stage II colon cancer patients
Background: We aimed to evaluate the cost-effectiveness of risk-based strategies to improve the selection of surgically treated stage II colon cancer (CC) patients for adjuvant chemotherapy. Methods: Using the ‘Personalized Adjuvant TreaTment in EaRly stage coloN cancer’ (PATTERN) model, we evaluate...
Main Authors: | Gabrielle Jongeneel, Marjolein J. E. Greuter, Felice N. van Erning, Miriam Koopman, Geraldine R. Vink, Cornelis J. A. Punt, Veerle M. H. Coupé |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-03-01
|
Series: | Therapeutic Advances in Gastroenterology |
Online Access: | https://doi.org/10.1177/1756284821995715 |
Similar Items
-
Model-based evaluation of the cost effectiveness of 3 6 months’ adjuvant chemotherapy in high-risk stage II colon cancer patients
by: Gabrielle Jongeneel, et al.
Published: (2020-09-01) -
Management of cytotoxic chemotherapy-induced hand-foot syndrome
by: Johannes J.M. Kwakman, et al.
Published: (2020-05-01) -
Implementation of an optical diagnosis strategy saves costs and does not impair clinical outcomes of a fecal immunochemical test-based colorectal cancer screening program
by: Jasper L. A. Vleugels, et al.
Published: (2017-11-01) -
Impact of differences in adenoma and proximal serrated polyp detection rate on the long-term effectiveness of FIT-based colorectal cancer screening
by: Maxime E. S. Bronzwaer, et al.
Published: (2018-04-01) -
Adjuvant Chemotherapy for Stage II Colon Cancer
by: Sara Elena Rebuzzi, et al.
Published: (2020-09-01)